ACIU logo

AC Immune SA (ACIU) CAPEX

Annual CAPEX

$892.00 K
-$407.10 K-31.34%

December 31, 2023

Summary

Performance

1-Year Change

-31.34%

3-Year Change

-50.98%

5-Year Change

-53.04%

15-Year Change

-51.24%

ACIU CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

34.85%
ACIU annual capital expenditures is higher than 34.85% of companies in Healthcare sector

High & Low

All-time High

$2.88 M
ACIU annual capital expenditures is currently -69.06% below its historical high of $2.88 million

3-Year Low

$892.00 K
ACIU annual capital expenditures is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ACIU previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
ACIU next annual earnings announcement has not yet been scheduled

OtherACIUcash flowmetrics:

Annual FCF

-$68.17 M
ACIU annual free cash flow is -$68.17 million

Annual CFO

-$67.27 M
ACIU annual cash flow from operations is -$67.27 million

Annual CFI

$73.11 M
ACIU annual cash flow from investing activities is $73.11 million

Annual CFF

$48.17 M
ACIU annual cash flow from financing activities is $48.17 million

Quarterly CAPEX

$211.50 K
+$145.90 K+222.41%

September 30, 2024

Summary

Performance

3-Month Change

+222.41%

1-Year Change

-25.76%

3-Year Change

+70.02%

5-Year Change

-55.84%

ACIU Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

37.06%
ACIU quarterly capital expenditures is higher than 37.06% of companies in Healthcare sector

High & Low

All-time High

$1.13 M
ACIU quarterly capital expenditures is currently -81.36% below its historical high of $1.13 million

3-Year Low

$58.70 K
ACIU quarterly capital expenditures is currently +260.31% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ACIU previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
ACIU next earnings announcement has not yet been scheduled

OtherACIUcash flowmetrics:

Quarterly FCF

-$12.81 M
ACIU quarterly free cash flow is -$12.81 million

Quarterly CFO

-$12.60 M
ACIU quarterly cash flow from operations is -$12.60 million

Quarterly CFI

-$7.45 M
ACIU quarterly cash flow from investing activities is -$7.45 million

Quarterly CFF

-$238.10 K
ACIU quarterly cash flow from financing activities is -$238.10 thousand

TTM CAPEX

$735.00 K
-$112.60 K-13.28%

September 30, 2024

Summary

Performance

3-Month Change

-13.28%

1-Year Change

-23.52%

3-Year Change

-63.96%

5-Year Change

-61.26%

ACIU TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

31.18%
ACIU TTM capital expenditures is higher than 31.18% of companies in Healthcare sector

High & Low

All-time High

$2.99 M
ACIU TTM capital expenditures is currently -75.45% below its historical high of $2.99 million

3-Year Low

$578.10 K
ACIU TTM capital expenditures is currently +27.14% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ACIU previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
ACIU next earnings announcement has not yet been scheduled

OtherACIUcash flowmetrics:

TTM FCF

$51.34 M
ACIU TTM free cash flow is $51.34 million

TTM CFO

$52.07 M
ACIU TTM cash flow from operations is $52.07 million

TTM CFI

-$92.20 M
ACIU TTM cash flow from investing activities is -$92.20 million

TTM CFF

$44.58 M
ACIU TTM cash flow from financing activities is $44.58 million

ACIU CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-31.3%-25.8%-23.5%
3 y3 years-51.0%+70.0%-64.0%
5 y5 years-53.0%-55.8%-61.3%

ACIU CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-69.1%at low-73.5%+260.3%-74.5%+27.1%
5 y5-year-69.1%at low-76.8%+260.3%-75.5%+27.1%
alltimeall time-69.1%+536.7%-81.4%+695.8%-75.5%+763.7%

AC Immune SA CAPEX History

DateAnnualQuarterlyTTM
Sep 2024
-
$211.50 K(+222.4%)
$735.00 K(-13.3%)
Jun 2024
-
$65.60 K(-77.0%)
$847.60 K(-11.8%)
Mar 2024
-
$284.90 K(+64.7%)
$961.00 K(+7.7%)
Dec 2023
$892.00 K(-31.3%)
$173.00 K(-46.6%)
$892.10 K(+14.7%)
Sep 2023
-
$324.10 K(+81.1%)
$777.80 K(+34.5%)
Jun 2023
-
$179.00 K(-17.1%)
$578.10 K(-37.9%)
Mar 2023
-
$216.00 K(+268.0%)
$930.50 K(-28.4%)
Dec 2022
$1.30 M(-54.9%)
$58.70 K(-52.8%)
$1.30 M(-36.3%)
Sep 2022
-
$124.40 K(-76.6%)
$2.04 M(-16.5%)
Jun 2022
-
$531.40 K(-9.1%)
$2.44 M(-5.9%)
Mar 2022
-
$584.60 K(-26.9%)
$2.59 M(-10.0%)
Dec 2021
$2.88 M(+58.4%)
$799.20 K(+51.7%)
$2.88 M(-3.7%)
Sep 2021
-
$526.80 K(-22.9%)
$2.99 M(+8.2%)
Jun 2021
-
$683.60 K(-21.7%)
$2.77 M(+11.9%)
Mar 2021
-
$873.40 K(-4.0%)
$2.47 M(+36.0%)
Dec 2020
$1.82 M(-4.1%)
$909.50 K(+202.1%)
$1.82 M(+22.9%)
Sep 2020
-
$301.10 K(-22.8%)
$1.48 M(-10.7%)
Jun 2020
-
$390.00 K(+78.0%)
$1.66 M(+3.4%)
Mar 2020
-
$219.10 K(-61.6%)
$1.60 M(-15.5%)
Dec 2019
$1.90 M
$570.80 K(+19.2%)
$1.90 M(+20.5%)
DateAnnualQuarterlyTTM
Sep 2019
-
$478.90 K(+43.0%)
$1.57 M(+27.1%)
Jun 2019
-
$334.80 K(-34.7%)
$1.24 M(-3.1%)
Mar 2019
-
$512.90 K(+107.0%)
$1.28 M(-32.7%)
Dec 2018
$1.90 M(+3.8%)
$247.80 K(+73.3%)
$1.90 M(+17.5%)
Sep 2018
-
$143.00 K(-61.8%)
$1.62 M(-9.8%)
Jun 2018
-
$374.00 K(-67.0%)
$1.79 M(-24.3%)
Mar 2018
-
$1.13 M(-3295.8%)
$2.37 M(+29.3%)
Dec 2017
$1.83 M(+100.5%)
-$35.50 K(-111.2%)
$1.83 M(-14.9%)
Sep 2017
-
$317.90 K(-66.5%)
$2.15 M(+0.3%)
Jun 2017
-
$948.50 K(+58.5%)
$2.14 M(+64.9%)
Mar 2017
-
$598.40 K(+110.5%)
$1.30 M(+42.4%)
Dec 2016
$912.60 K(+259.9%)
$284.30 K(-8.9%)
$912.60 K(+43.9%)
Sep 2016
-
$312.10 K(+197.8%)
$634.20 K(+42.3%)
Jun 2016
-
$104.80 K(-50.4%)
$445.60 K(+17.3%)
Mar 2016
-
$211.40 K(+3483.1%)
$379.90 K(+49.8%)
Dec 2015
$253.60 K(+81.0%)
$5900.00(-95.2%)
$253.60 K(+2.4%)
Sep 2015
-
$123.50 K(+215.9%)
$247.70 K(+99.4%)
Jun 2015
-
$39.10 K(-54.1%)
$124.20 K(+45.9%)
Mar 2015
-
$85.10 K
$85.10 K
Dec 2014
$140.10 K
-
-

FAQ

  • What is AC Immune SA annual capital expenditures?
  • What is the all time high annual CAPEX for AC Immune SA?
  • What is AC Immune SA annual CAPEX year-on-year change?
  • What is AC Immune SA quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for AC Immune SA?
  • What is AC Immune SA quarterly CAPEX year-on-year change?
  • What is AC Immune SA TTM capital expenditures?
  • What is the all time high TTM CAPEX for AC Immune SA?
  • What is AC Immune SA TTM CAPEX year-on-year change?

What is AC Immune SA annual capital expenditures?

The current annual CAPEX of ACIU is $892.00 K

What is the all time high annual CAPEX for AC Immune SA?

AC Immune SA all-time high annual capital expenditures is $2.88 M

What is AC Immune SA annual CAPEX year-on-year change?

Over the past year, ACIU annual capital expenditures has changed by -$407.10 K (-31.34%)

What is AC Immune SA quarterly capital expenditures?

The current quarterly CAPEX of ACIU is $211.50 K

What is the all time high quarterly CAPEX for AC Immune SA?

AC Immune SA all-time high quarterly capital expenditures is $1.13 M

What is AC Immune SA quarterly CAPEX year-on-year change?

Over the past year, ACIU quarterly capital expenditures has changed by -$73.40 K (-25.76%)

What is AC Immune SA TTM capital expenditures?

The current TTM CAPEX of ACIU is $735.00 K

What is the all time high TTM CAPEX for AC Immune SA?

AC Immune SA all-time high TTM capital expenditures is $2.99 M

What is AC Immune SA TTM CAPEX year-on-year change?

Over the past year, ACIU TTM capital expenditures has changed by -$226.00 K (-23.52%)